Status:
COMPLETED
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
Lead Sponsor:
AstraZeneca
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy of quetiapine fumarate sustained release (Seroquel SR™) in combination with an antidepressant versus an antidepressant alone in patients with Major Depressive Disorder. PLEAS...
Eligibility Criteria
Inclusion
- Male or female aged 18 to 65 years
- A documented diagnosis of major depressive disorder
Exclusion
- Patients with a DSM IV Axis I disorder other than MDD within 6 months of enrolment
- Patients with a diagnosis of DSM IV Axis II disorder which has a major impact on the patient's current psychiatric status
- Patients whose current episode of depression exceeds 12 months or is less than 4 weeks prior to enrolment
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
494 Patients enrolled
Trial Details
Trial ID
NCT00351910
Start Date
May 1 2006
End Date
April 1 2007
Last Update
January 26 2011
Active Locations (72)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Everton Park, Queensland, Australia
2
Research Site
Southport, Queensland, Australia
3
Research Site
Frankston, Victoria, Australia
4
Research Site
Malvern, Victoria, Australia